Fauvelle, Khristina
Bigna, Jean Joel http://orcid.org/0000-0001-8018-6279
Funding for this research was provided by:
Sanofi-Aventis France
Article History
Accepted: 28 August 2022
First Online: 26 October 2022
Change Date: 20 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-022-01268-y
Declarations
:
: All four surveys were funded by Sanofi, France.
: Khristina Fauvelle and Jean Joel Bigna are employees of Sanofi, FranceĀ and may hold shares and/or stock options in the company.
: This article does not contain data from any individual. According to the French Public Health code, ethics committee approval or the granting of exemption of ethic committee approval is not a prerequisite for research not involving human subjects.
: Data analyzed in this survey were provided by pharmacists and were not collected data from patients. As this study did not include any patient/person, written patient consent was not required. Verbal consent was requested before including participants in the surveys.
: Not applicable.
: All data generated by the surveys conducted in 2018 and 2020 are provided in full in this article. The datasets generated by the surveys conducted in 2016 and 2017 are available on the ANSM website at: ExternalRef removed.
: Codes generated during the current study are not publicly available but are available from the corresponding author on reasonable request.
: KF participated in the conception and design of the study, provided data, contributed to data analysis and interpretation, and reviewed several versions of the manuscript. JJB contributed to the interpretation of the data and reviewed several versions of the manuscript. KF and JJB approved the final version of the manuscript and its submission for publication.